|
Volumn 24, Issue 5, 2002, Pages 1-5
|
Informed consent for Alzheimer's disease clinical trials: a survey of clinical investigators.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALZHEIMER DISEASE;
ARTICLE;
ATTITUDE TO HEALTH;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLINICAL TRIAL;
CUSTODY;
EMPIRICAL APPROACH;
GOVERNMENT;
GOVERNMENT REGULATION;
HUMAN;
INFORMATION PROCESSING;
INFORMED CONSENT;
MENTAL CAPACITY;
PATIENT SELECTION;
PERSONNEL;
PROFESSIONAL STANDARD;
RESEARCH SUBJECT;
STANDARD;
UNITED STATES;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
EMPIRICAL APPROACH;
ALZHEIMER DISEASE;
CLINICAL TRIALS;
CONSENT FORMS;
DATA COLLECTION;
ETHICS COMMITTEES, RESEARCH;
GOVERNMENT REGULATION;
HEALTH KNOWLEDGE, ATTITUDES, PRACTICE;
HUMANS;
INFORMED CONSENT;
MENTAL COMPETENCY;
PATIENT SELECTION;
PROXY;
RESEARCH PERSONNEL;
RESEARCH SUBJECTS;
STATE GOVERNMENT;
THIRD-PARTY CONSENT;
UNITED STATES;
MLCS;
MLOWN;
|
EID: 0038148155
PISSN: 01937758
EISSN: None
Source Type: Journal
DOI: 10.2307/3563802 Document Type: Article |
Times cited : (40)
|
References (0)
|